Photofrin porfimer sodium: Phase III; marketed for the palliative treatment of obstructive esophageal cancer and endobronchial non-small cell lung cancer

In an Phase III trial in 208 patients followed for a

Read the full 117 word article

How to gain access

Continue reading with a
two-week free trial.